Dermapharm Holding SE (DMPHF)

PNK: DMPHF · Real-Time Price · USD

39.56

0.00 (0.00%)

At close: Apr 25, 2025, 9:30 AM

Dermapharm SE Income Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016
Revenue	290.67M	311.6M	283.8M	301.42M	274.14M	284.47M	262.97M	319.12M	290.52M	263.14M	239.48M	231.64M	272.72M	242.45M	215.54M	212.21M	216.66M	198.98M	185.73M	192.47M	183.3M	184.41M	169.62M	163.55M	143.47M	148.7M	142.76M	137.49M	117.43M	115.46M	116.15M	118.07M	125.26M
Cost of Revenue	97.49M	115.23M	105.49M	102.22M	113.71M	109.44M	106.66M	106.74M	91.69M	99.87M	87.36M	85.02M	86.18M	85.45M	71.79M	78.8M	83.54M	83.13M	77.47M	86.2M	79.66M	86.91M	78.21M	72.38M	63.69M	73.47M	71.5M	64M	58.09M	63.51M	62.32M	61.72M	71.43M
Gross Profit	193.18M	196.37M	178.32M	199.2M	160.43M	175.02M	156.31M	212.38M	198.82M	163.27M	152.12M	146.62M	186.54M	157M	143.74M	133.41M	133.11M	115.84M	108.25M	106.27M	103.64M	97.49M	91.41M	91.17M	79.77M	75.23M	71.27M	73.5M	59.33M	51.95M	53.84M	56.35M	53.83M
Operating Income	47.86M	66.14M	37.24M	65.69M	37.01M	51.18M	10.4M	84.3M	76.81M	75.84M	32.94M	58.09M	101.38M	85.06M	60.26M	51.78M	37.47M	34.55M	25.11M	39.72M	32.49M	29.76M	28.49M	28.76M	25.27M	28.28M	23.55M	30.42M	21.67M	23.51M	21.78M	25.16M	21.74M
Interest Income	-2.64M	5.26M	4.8M	13.43M	n/a	913K	6.48M	425K	n/a	84K	57K	1.09M	1.36M	201K	2.46M	106K	62K	79K	102K	291K	n/a	1.87M	2.22M	113K	n/a	513K	1.87M	340K	n/a	675K	2.29M	312K	n/a
Pretax Income	34.55M	46.8M	26.79M	63.86M	4.31M	34.81M	-2.91M	69.79M	56.77M	72.36M	29.77M	57.4M	101.61M	82.63M	59.71M	49.02M	34.99M	31.63M	21.87M	36.79M	27.45M	27.68M	27.71M	27.22M	24.28M	27.46M	22.63M	29.86M	20.88M	22.67M	20.3M	24.18M	21.04M
Net Income	20.51M	32.39M	17.27M	43.62M	-2.69M	24.84M	-9.19M	49.4M	29.89M	52.45M	14.52M	37.37M	71.65M	61.81M	39.82M	36.31M	24.54M	22.65M	11.97M	26.66M	18.73M	19.25M	20.06M	19.16M	15.02M	22.31M	16.6M	21.39M	61.31M	8.01M	4.79M	20.29M	6.02M
Selling & General & Admin	n/a	n/a	73.88M	n/a	74.36M	41.58M	25.05M	49.56M	28.24M	33.16M	30.82M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Research & Development	n/a	n/a	n/a	n/a	19.89M	n/a	n/a	n/a	20.87M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	145.32M	130.23M	67.19M	133.51M	29.17M	7.53M	2.71M	10.31M	9M	4.47M	3.3M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	145.32M	130.23M	141.07M	133.51M	41.67M	123.84M	145.91M	128.08M	123.65M	87.42M	119.18M	88.53M	96.59M	71.94M	83.49M	81.63M	87.22M	81.29M	83.15M	66.55M	70.92M	67.73M	62.92M	62.41M	53.15M	46.95M	47.72M	43.08M	38.96M	28.44M	32.06M	31.2M	32.78M
Interest Expense	11.53M	17.89M	15.47M	15.49M	15.82M	18.96M	14.09M	13.63M	4.99M	3.18M	2.62M	2.46M	1.31M	3.1M	2.61M	2.46M	1.42M	3M	2.78M	2.73M	2.21M	4.13M	3.48M	2.1M	n/a	1.71M	3.18M	1.28M	n/a	1.94M	4.21M	1.66M	1.68M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	242.81M	245.46M	246.56M	233M	237.13M	233.28M	252.57M	234.82M	215.34M	187.3M	206.54M	173.56M	182.76M	157.39M	155.28M	160.43M	170.76M	164.43M	160.62M	152.75M	150.58M	154.64M	141.13M	134.79M	116.84M	120.43M	119.21M	107.08M	97.06M	91.95M	94.38M	92.92M	104.22M
Income Tax Expense	15.5M	14.03M	9.95M	20.79M	7.67M	10.53M	6.57M	20.69M	27.66M	20.45M	15.31M	20.27M	30.2M	20.95M	20.16M	12.78M	10.71M	9.06M	9.61M	9.98M	8.36M	8.36M	7.54M	8M	9.19M	5.32M	6.03M	8.47M	5.99M	-662K	1.07M	3.9M	-97K
Shares Outstanding (Basic)	53.96M	n/a	53.96M	53.85M	54.05M	53.84M	53.84M	53.84M	53.84M	53.25M	53.77M	53.84M	53.72M	53.66M	53.81M	53.84M	54.08M	53.96M	54.41M	53.33M	54.44M	53.48M	52.79M	53.21M	53.58M	54.57M	53.56M	52.16M	50.1M	50.1M	12.28M	49.49M	50.1M
Shares Outstanding (Diluted)	53.96M	n/a	53.96M	53.85M	54.05M	53.84M	53.84M	53.84M	53.84M	53.25M	53.77M	54.16M	53.72M	53.66M	53.81M	54.2M	54.08M	53.96M	54.41M	53.33M	54.44M	53.48M	52.79M	53.21M	53.58M	54.57M	53.56M	52.16M	53.84M	53.84M	12.28M	49.49M	53.84M
EPS (Basic)	0.38	n/a	0.32	0.81	-0.05	0.46	-0.17	0.92	0.56	0.98	0.27	0.69	1.33	1.15	0.74	0.67	0.45	0.42	0.22	0.50	0.34	0.36	0.38	0.36	0.28	0.41	0.31	0.41	0.30	1.09	0.39	0.41	1.32
EPS (Diluted)	0.38	n/a	0.32	0.81	-0.05	0.46	-0.17	0.92	0.56	0.98	0.27	0.69	1.33	1.15	0.74	0.67	0.45	0.42	0.22	0.50	0.34	0.36	0.38	0.36	0.28	0.41	0.31	0.41	0.28	1.01	0.39	0.41	1.23
EBITDA	72.24M	85.45M	66.08M	77.02M	65.95M	74.51M	45.5M	89.09M	97.44M	89.36M	71.33M	72.43M	122.7M	85.57M	68.35M	62.91M	51.86M	46.12M	36.4M	49.46M	42.88M	44.57M	37.27M	40.83M	36.66M	35.96M	29M	34.16M	25.56M	28.95M	24.1M	27.69M	26.11M
EBIT	46.08M	64.69M	28.45M	79.35M	15.44M	53.77M	11.18M	83.42M	61.61M	75.54M	32.38M	59.86M	102.92M	85.73M	62.31M	51.48M	36.41M	34.63M	25.11M	39.53M	28.93M	31.81M	31.19M	29.33M	24.15M	29.18M	25.81M	31.14M	20.25M	24.61M	24.51M	25.84M	21.95M
Depreciation & Amortization	24.49M	20.35M	22.29M	19.65M	6.79M	20.33M	33.7M	15.1M	29.78M	13.68M	38.91M	12.54M	19.6M	12.62M	11.64M	11.29M	14.7M	11.57M	11.29M	9.86M	13.39M	12.38M	11.01M	11.1M	12.51M	6.02M	7.13M	4.67M	4.99M	4.04M	3.42M	3.41M	3.82M